(Oct. 22, 2021) – This week, a special state legislative interim, chaired by Representative Susan Concannon (R-Beloit), met to discuss the federal 340B Drug Program. Kansas Hospital Association members appeared before the committee to highlight the importance of the program and what is at stake if the program is allowed to be eroded.
Presenting on behalf of health care providers were:
- Sarah Dodson, Ascension Via Christi Hospital Pittsburg, Inc., Pittsburg
- Tracy Gilmore, Labette Health, Parsons
- Representatives of the Community Care Network of Kansas, Topeka
Next, the committee received an overview and historical information from:
- Lisa Scholz, Sentry Data Systems
- William Von Oehsen, attorney for Powers, Pyles, Sutter & Verville.
The committee then received an update at the state and federal level from:
- Steven Anderson, Medicaid inspector general
- Jake Middlebrooks, legislative director for Congressman Jake LaTurner.
Finally, committee members heard testimony from Carolyn Ha, PhRMA, who raised questions about whether patients are receiving the benefits, and whether profits are being diverted for PBM's purposes. The conferee emphasized the need for increased transparency in 340B.